Robb Richards, MS, MBA is the corporate director of the Cell Therapy and Transplant program at Penn Medicine, with oversight of both commercial and research work, as well as a focus on expansion into community hospitals within the Penn system. With over 20 years of experience in oncology (including bone marrow transplant and CAR T-cell therapy), oncology analytics, EMR integration, information technology, business management of oncology practices, he has been the lead in overseeing the implementation and operations of CAR T-cell therapy for commercial use.
Richards earned his MS and MBA from St. Joseph’s University in Pennsylvania, specializing in oncology informatics, and his bachelor’s degree from Drexel University.
